Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Use camera
Select from library
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Goodbye! and best wishes in your recovery
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Arg, Kabul, Afghanistan

Total all time reports:  1
Latest report: April 21, 2020 12:00 PM
20 Afghan Presidential Staff workers test positive for COVID-19, Arg, Kabul, Afghanistan

20 Afghan Presidential Staff workers test positive for COVID-19

April 21, 2020 12:00 PM

“At least 20 officials working at Afghan President palace in Kabul have have tested positive for the coronavirus.

Source: rferl.org See Less
Reported By SafelyHQ.com User

Related Reports

August 9, 2020 12:00 PM

“A staff members at The Deck at Pere Marquette Park at 1601 Beach St. tested positive for COVID-19 at the end of July.

Source: mlive.com See Less
Reported By SafelyHQ.com User

August 9, 2020 12:00 PM

“An employee at a Dairy Queen in West Duluth, located at 4431 Grand Ave tested positive for COVID-19 on Friday August 7.

Source: duluthnewstribune.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, Hunter Lake Elementary School, 909 Hunter Lake Dr, Reno, NV 89509, USA

Hunter Lake Elementary School, 909 Hunter Lake Dr, Reno, NV 89509, USA

August 9, 2020 12:00 PM

“A Hunter Lake Elementary School staff member in Reno tested positive for COVID-19 on August 7.

Source: mynews4.com See Less
Reported By SafelyHQ.com User

Five confirmed cases of Covid-19, The Crossing at Union Cross Church, 1650 Pecan Ln, Winston-Salem, NC 27107, USA

The Crossing at Union Cross Church, 1650 Pecan Ln, Winston-Salem, NC 27107, USA

August 9, 2020 12:00 PM

“Three children and two staff members at the Crossing at Union Cross Church's Preschool Afterschool program in Kernersville have tested positive for Covid-19. All cases stem from exposure at the vacation bible school.

Source: wfmynews2.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, Polson School District Superintendent, 111 4th Ave E, Polson, MT 59860, USA

Polson School District Superintendent, 111 4th Ave E, Polson, MT 59860, USA

August 9, 2020 12:00 PM

“An employee at the Polson School District summer meal program tested positive for COVID-19 on July 28

Source: See Less
Reported By SafelyHQ.com User

August 9, 2020 12:00 PM

“80 workers at O'Briens Fine Food in Co Kildare have tested positive for Covid-19.

Source: irishtimes.com See Less
Reported By SafelyHQ.com User

August 9, 2020 12:00 PM

“A Broward school district employee at the K.C. Wright administrative building in Fort Lauderdale tested positive for the new coronavirus on August 7.

Source: sun-sentinel.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, Joaquin Superintendent Office, 11109 U.S. 84, Joaquin, TX 75954, USA

Joaquin Superintendent Office, 11109 U.S. 84, Joaquin, TX 75954, USA

August 9, 2020 12:00 PM

“A Joaquin Independent School District employee tested positive for COVID-19 on Friday August 7 and multiple other employees are self-quarantining.

Source: easttexasmatters.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, The Catholic Diocese of Evansville, 4200 N Kentucky Ave, Evansville, IN 47711, USA

The Catholic Diocese of Evansville, 4200 N Kentucky Ave, Evansville, IN 47711, USA

August 9, 2020 12:00 PM

“A staff member at a Catholic Diocese of Evansville school tested positive for Covid-19 on August 8. The school the employee worked at was not identified.

Source: tristatehomepage.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, Cuyahoga Heights Schools, 4820 E 71st St, Cleveland, OH 44125, USA

Cuyahoga Heights Schools, 4820 E 71st St, Cleveland, OH 44125, USA

August 9, 2020 12:00 PM

“A trades crew member for the Heights Schools tested positive for COVID-19 last week on July 30.

Source: patch.com See Less
Reported By SafelyHQ.com User

Recent Interesting Reports

June 18, 2020 11:00 PM

“Company name: GSK Consumer Healthcare
Brand name: Robitussin
Product recalled: Cough and cold products
Reason of the recall: Incorrect dosing cups
FDA Recall date: June 18, 2020
Recall details: GSK Consumer Healthcare is voluntarily recalling to the retail level two lots (listed below) of Ch ... See Moreildren's Robitussin® Honey Cough and Chest Congestion DM and one lot of Children's Dimetapp® Cold and Cough, due to the inclusion of incorrect dosing cups. During the review of the packaging documents for these products, GSK discovered that the dosing cups for the Children's Robitussin® Honey product are missing the 5 mL and 10 mL graduations, while the dosing cups for the Children's Dimetapp® product are missing the 10 mL graduation. The dosing cups packaged with both products only have the 20 mL graduation.

There is a potential risk of accidental overdose if caregivers dispensing the syrup do not notice the discrepancies between the graduations printed on the dosing cups and the indicated amounts to be administered (as directed in the instructions for use). Children's Robitussin Honey Cough & Chest Congestion DM contains 10 mg dextromethorphan HBr USP and guaifenesin USP 100 mg per 10 mL, and is labeled for children 4 and older, as well as adults. Children's Dimetapp Cold & Cough contains 2 mg brompheniramine maleate USP, 10 mg dextromethorphan HBr USP, and 5 mg phenylephrine HCl USP per 10 mL, and is labeled for children 6 and older, as well as adults.

Symptoms of overdose of either product may include any of the following: impaired coordination; brain stimulation causing increase in energy, elevation in blood pressure, heart rate, and respiration; a lack of energy and enthusiasm; severe dizziness or drowsiness; slow heart rate; fainting; psychotic behaviour; restlessness; seizure; decreased respiration; nausea; vomiting; constipation; diarrhea; abdominal pain; visual and hearing hallucinations; urinary retention.

As of the date of the recall announcement, GSK Consumer Healthcare has not received any adverse events related to these products or consumer complaints regarding the incorrect dosing cups supplied with the product. The recall is limited to the three lots listed below:

Children's Robitussin® Honey Cough and Chest Congestion DM (4oz)
NDC 0031-8760-12
Lots: 02177 (Exp. Jan. 2022) / 02178 (Exp. Jan. 2022)

Children's Dimetapp® Cold and Cough (8oz)
NDC 0031-2234-19
Lot: CL8292 (Exp. Sep. 2021)

These lots were distributed nationwide between February 5, 2020 and June 3, 2020 within the United States. GSK Consumer Healthcare has notified wholesalers, distributors and retailers to arrange for return of any recalled product. Wholesalers, distributors and retailers with an existing inventory of the lots being recalled should stop distribution and quarantine these lots immediately.

Wholesalers, distributors and retailers that have further distributed the recalled product should notify any accounts or additional locations which may have received the recalled product from them. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. In December 2018, GlaxoSmithKline plc reached an agreement with Pfizer, Inc. to combine their consumer health businesses into a new Joint Venture. August 01, 2019 was the first day of the new GSK Consumer Healthcare Joint Venture. Thus, when identifying impacted product, please be aware the Pfizer company name will still be present on the label.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

July 15, 2020 5:32 AM

“We love a bit of raw chicken and hair in our food! Absolutely disgusting See Less
Reported By SafelyHQ.com User

May 7, 2020 1:00 PM

“Company name: Becca Cosmetics
Brand name: Becca Cosmetics
Product recalled: Light Shifter Brightening Concealer
Reason of the recall: Potential Mold
FDA Recall date: May 07, 2020
Recall details: Company Announcement Out of abundance of caution, and in line with its commitment to consumer sat ... See Moreisfaction and safety, Becca Cosmetics is voluntarily recalling all shades of its Light Shifter Brightening Concealer because a brownish-black material identified as a common household mold was found on the sponge-tip applicator of some units. While this is unlikely to cause serious injury there is a potential risk of temporary skin and/or eye allergy and irritation.

To date, no adverse reactions or injuries have been reported. This product was manufactured in the United States and distributed nationwide. The below are the details of the product affected by this recall. No other Becca Cosmetics products are affected by this issue.

- Product Name: Becca Cosmetics Light Shifter Brightening Concealer
- Batch: 0030A, 9308A, 0052A, 0052C, 9291A, 9309A, 0036A, 0037A, 0038A, 0038B, 0041A, 9289A, 0062A, 0062B, 0062C, 9283A, 9284A, 9287A, 9288A
- Size: 3.2 mL (only size available)
- Product Description: Concealer wand with silver overlay, and a white secondary carton
- UPC: 9331137030037, 9331137030044, 9331137030051, 9331137030068, 9331137030075, 9331137030099, 9331137030082, 9331137030105

If you have this product, please stop using it and contact the place of purchase regarding a refund. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

July 21, 2020 5:45 AM

“raw chicken sandwich. It’s what’s for dinner apparently See Less
Reported By SafelyHQ.com User

July 22, 2020 6:01 PM

“Company name: Fresenius Kabi USA
Brand name: Fresenius Kabi
Product recalled: Dexmedetomidine Hydrochloride Injection, 200 mcg/50 mL
Reason of the recall: Cross contamination with lidocaine
FDA Recall date: July 22, 2020
Recall details: Fresenius Kabi USA is voluntarily recalling two lots of De ... See Morexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial. Fresenius Kabi initiated this recall due to the possibility of a trace amount of lidocaine present in these two lots and our investigation indicates that this issue is limited to these two product lots. This recall is being performed to the user level.

To date, no adverse drug experience reports have been received for either of the lots being recalled by Fresenius Kabi. Administration of Dexmedetomidine HCl containing trace amounts of lidocaine to a patient with lidocaine allergy, however, could result in anaphylaxis, a potentially life-threatening condition. Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection is approved for intravenous use and indicated for sedation of non-intubated patients prior to and/or during surgical and other procedures. Below there is a list of the recalled lots distributed nationwide to wholesalers, distributors, hospitals, and pharmacies between June 3, 2019 and April 8, 2020, as well as a copy of the label:

Product Name/Product size: Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial
NDC Number: 63323-671-50
Product Code: 671050
Batch Number: 6121853 - 6122207
Expiration Date: 05/2021 - 06/2021
First Ship Date 06/03/2019 - 12/04/2019
Last Ship Date: 03/12/2020 - 04/08/2020

Fresenius Kabi is notifying its distributors and customers by letter and asking customers and distributors to check their stock immediately and to quarantine and discontinue the use and distribution of any affected product.

Distributors should notify their customers and direct them to quarantine and discontinue distributing or dispensing any affected lots, and to return the product to Fresenius Kabi.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

June 3, 2020 3:34 PM

“Shoutout them for giving me raw chicken nuggets tonight. See Less
Reported By SafelyHQ.com User

June 11, 2020 1:00 PM

“Company name: Lupin Pharmaceuticals, Inc
Brand name: Lupin
Product recalled: Metformin Hydrochloride Extended-release Tablets
Reason of the recall: Detection of N-Nitrosodimethylamine (NDMA)
FDA Recall date: June 11, 2020
Recall details: Lupin Pharmaceuticals Inc. is voluntarily recalling Met ... See Moreformin Hydrochloride Extended-Release Tablets USP (generic equivalent of Fortamet®), 500mg, lot G901203 to the consumer level. FDA analysis revealed that this lot exceeded the Acceptable Daily Intake Limit for the impurity N-Nitrosodimethylamine (NDMA). To date, Lupin Pharmaceuticals Inc. has not received any reports of adverse events related to this recall.

Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products and vegetables. Metformin Hydrochloride Extended-Release Tablets USP, 500mg is a prescription oral medication indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus. It is packaged in a bottle containing 60 tablets with NDC 68180-336-07. The affected lot of Metformin Hydrochloride Extended-Release Tablets USP, 500mg is included in below table:

- Product Name: Metformin Hydrochloride Extended-Release Tablets USP, 500mg

- NDC: 68180-336-07

- Lot Number: G901203

- Expiration Date: 12/2020

The product can be identified by the NDC and the lot number available on the side of the bottle label. Metformin Hydrochloride Extended-Release Tablets USP, 500mg was distributed nationwide in the USA to wholesalers, distributors, and mail order pharmacies.

Lupin Pharmaceuticals Inc. is notifying its wholesalers, distributors, and mail order pharmacies by phone and through recall notification and is arranging for the return of all the recalled product lot. Patients taking Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, are advised to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment. According to the U.S. Food & Drug Administration, it could be dangerous for patients with this serious condition to stop taking their metformin without first talking to their health care professionals.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

August 10, 2020 12:37 AM

“Company name: Soluciones Cosmeticas
Brand name: Bersih
Product recalled: Hand Sanitizer Gel
Reason of the recall: Potential Methanol Contamination
FDA Recall date: August 09, 2020
Recall details: Company Announcement Soluciones Cosméticas voluntary recalled all lots of Bersih Hand Sanitizer Gel ... See MoreFragrance Free sold in 16.9 ounce bottles to the consumer level. The products are being recalled due to the potential presence of methanol (wood alcohol). This release provides additional information about the packaging for the recalled products. Risk Statement: Substantial methanol exposure can result in nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma, permanent damage to the nervous system or death. Although all persons using these products on their hands are at risk, young children who accidently ingest these products and adolescents and adults who drink these products as an alcohol (ethanol) substitute, are most at risk for methanol poisoning. To date Soluciones Cosméticas has not received reports of adverse events related to this recall. The product is used as a hand sanitizer and is packaged in 16.9 ounce plastic clear bottles with blue tops or green tops with UPC Codes 816822026667 or 7503007103178. The lot numbers range from 0100K01 to 0148K01. This product was distributed nationwide to wholesale distributors and retailers. Soluciones Cosméticas is notifying its distributors by voluntary recall letter and consumers via this press release. Consumers that have the product subject to this recall should stop using and either contact Soluciones Cosméticas per the below for disposal instructions or return it to the place of purchase. Consumers with questions regarding this recall can contact Soluciones Cosméticas at  866-912-8410 Monday through Friday 8am to 5pm Eastern Time or by email at bersihrecall6551@stericycle.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Complete and submit the report Online
Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. Original Press Release FDA updates on hand sanitizers consumers should not use.
Check the full recall details on fda.gov
Source: FDA
See Less
Reported By SafelyHQ.com User

July 16, 2020 5:32 PM

“gotta love getting raw chicken from here! absolutely shocking! at least i won’t be dying from covid...i’ll be dying from salmonella instead See Less
Reported By SafelyHQ.com User

May 26, 2020 3:35 AM

“Disgraceful raw chicken was totally all pink from there
what can be done about this? See Less
Reported By SafelyHQ.com User